0000950170-24-077346.txt : 20240625
0000950170-24-077346.hdr.sgml : 20240625
20240625163822
ACCESSION NUMBER: 0000950170-24-077346
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240621
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mathers Edward T
CENTRAL INDEX KEY: 0001328625
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 241069435
MAIL ADDRESS:
STREET 1: C/O MEDIMMUNE, INC.
STREET 2: ONE MEDIMMUNE WAY
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
ownership.xml
4
X0508
4
2024-06-21
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001328625
Mathers Edward T
104 5TH AVE
NEW YORK
NY
10011
true
false
false
false
false
Common Stock
2024-06-21
4
M
false
3000
A
3000
D
Common Stock
5771
I
See Note 2
Restricted Stock Units
2024-06-21
4
M
false
3000
0
D
Common Stock
3000
0
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The Reporting Person is the trustee of the Edward Timothy Mathers Revocable Trust (the "Mathers Trust"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest.
The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date.
/s/ Zachary Bambach, attorney-in-fact
2024-06-25